Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
ACS Nano|July 9, 2025
Oxygen-Generating Transdermal Nanoplatform Codelivering BRD4 Proteolysis-Targeting Chimera/Verteporfin/CaO2 Synergistically Remodels Immunosuppressive Melanoma Microenvironment to Potentiate Combination ImmunotherapyMingli Wei, Tian Yin, Chenxiao Chu, et al.Colloids and Surfaces. B, Biointerfaces|December 3, 2021
Two-step fabricating micelle-like nanoparticles of cisplatin with the 'real' long circulation and high bioavailability for cancer therapyHongbing Liu, Xiaowen Li, Muse Ji, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 9, 2025
Irinotecan and dexamethasone prodrug co-loaded liposomes for the treatment of breast cancerMei Chen, Hongbing Liu, Mengqi Xiu, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|August 12, 2023
Integration of MyD88 inhibitor into mesoporous cerium oxide nanozymes-based targeted delivery platform for enhancing treatment of ulcerative colitisHongbing Liu, Muse Ji, Yuti Bi, et al.Biomaterials Science|August 7, 2023
pH-Activatable copper-axitinib coordinated multifunctional nanoparticles for synergistic chemo-chemodynamic therapy against aggressive cancersMuse Ji, Hongbing Liu, Hanxun Wang, et al.International Journal of Pharmaceutics|April 1, 2026
Dual-targeted and ROS-responsive dexamethasone prodrug liposomes for enhanced therapy of acute lung injuryXinlu Song, Mei Chen, Hongbing Liu, et al.International Journal of Pharmaceutics|March 23, 2026
A triamcinolone acetonide palmitate nanoemulsion eye drop delivered by iontophoresis for the management of posterior uveitisRuolan Xiang, Xiaoshuang Bi, Dongmei Shi, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 21, 2026
A sea buckthorn seed oil nano-emulsion in the management of digital screen-induced ocular conditionsMengfan Cheng, Xiaoshuang Bi, Shan Zhao, et al.International Journal of Pharmaceutics|January 13, 2024
Activate the endogenous Cu2+ switch for Zn(DDC)2 liposomes conversion: Providing a safer and less toxic alternative in cancer therapyXinxin Liang, Chunxue Li, Wei Yuan, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 7, 2026
Decoupling efficacy from toxicity: Inhalable liposomal nintedanib for safe and effective treatment of pulmonary fibrosisXinxin Mu, Chunwen Zeng, Hongbing Liu, et al.Pageof 3